Your browser doesn't support javascript.
loading
Afatinib plus osimertinib in the treatment of osimertinib-resistant non-small cell lung carcinoma: a phase I clinical trial.
Miura, Satoru; Koh, Yasuhiro; Azuma, Koichi; Yoshioka, Hiroshige; Koyama, Kenichi; Teraoka, Shunsuke; Ishii, Hidenobu; Kibata, Kayoko; Ozawa, Yuichi; Tokito, Takaaki; Oyanagi, Jun; Shimokawa, Toshio; Kurata, Takayasu; Yamamoto, Nobuyuki; Tanaka, Hiroshi.
Afiliação
  • Miura S; Department of Internal Medicine, Niigata Cancer Center Hospital, 2-15-3 Kawagishicho, Chuo-ku, Niigata, Niigata, 951-8566, Japan. miusat1118@niigata-cc.jp.
  • Koh Y; Internal Medicine III, Wakayama Medical University, 811-1, Kimiidera, Wakayama, 641-8509, Japan.
  • Azuma K; Center for Biomedical Sciences, Wakayama Medical University, 811-1, Kimiidera, Wakayama, 641-8509, Japan.
  • Yoshioka H; Division of Respirology, Neurology, and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine 67 Asahi-machi, Kurume, 830-0011, Japan.
  • Koyama K; Department of Thoracic Oncology, Kansai Medical University Hospital, 3-1, Shinmachi 2 Chome, Hirakata, Osaka, 573-1191, Japan.
  • Teraoka S; Department of Internal Medicine, Niigata Cancer Center Hospital, 2-15-3 Kawagishicho, Chuo-ku, Niigata, Niigata, 951-8566, Japan.
  • Ishii H; Internal Medicine III, Wakayama Medical University, 811-1, Kimiidera, Wakayama, 641-8509, Japan.
  • Kibata K; Division of Respirology, Neurology, and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine 67 Asahi-machi, Kurume, 830-0011, Japan.
  • Ozawa Y; Department of Thoracic Oncology, Kansai Medical University Hospital, 3-1, Shinmachi 2 Chome, Hirakata, Osaka, 573-1191, Japan.
  • Tokito T; Internal Medicine III, Wakayama Medical University, 811-1, Kimiidera, Wakayama, 641-8509, Japan.
  • Oyanagi J; Division of Respirology, Neurology, and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine 67 Asahi-machi, Kurume, 830-0011, Japan.
  • Shimokawa T; Internal Medicine III, Wakayama Medical University, 811-1, Kimiidera, Wakayama, 641-8509, Japan.
  • Kurata T; Center for Biomedical Sciences, Wakayama Medical University, 811-1, Kimiidera, Wakayama, 641-8509, Japan.
  • Yamamoto N; Clinical Study Support Center, Wakayama Medical University, 811-1, Kimiidera, Wakayama, 641-8509, Japan.
  • Tanaka H; Department of Thoracic Oncology, Kansai Medical University Hospital, 3-1, Shinmachi 2 Chome, Hirakata, Osaka, 573-1191, Japan.
BMC Cancer ; 23(1): 6, 2023 Jan 03.
Article em En | MEDLINE | ID: mdl-36597021
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article